Open AccessCost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies
Author(s) -
Andrew Palmer,
Daniel M. Tucker,
William J. Valentine,
Stéphane Roze,
Sylvie Gabriel,
D Cordonnier
Publication year - 2005
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfh802
Subject(s) - irbesartan , medicine , amlodipine , diabetic nephropathy , cost effectiveness , nephropathy , diabetes mellitus , intensive care medicine , blood pressure , endocrinology , risk analysis (engineering)
To review published studies on the cost-effectiveness of the use of irbesartan for treatment of advance overt nephropathy in patients with type 2 diabetes and hypertension.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom